HLA-B*57:01 Genotyping is a pharmacogenetic test used to identify the presence of the HLA-B*57:01 allele, which is strongly associated with abacavir hypersensitivity reactions. This test is essential before initiating abacavir-based HIV therapy, helping clinicians prevent severe, potentially life-threatening adverse drug reactions. Performed using PCR-based methods, it ensures safe and personalized treatment planning.
Fasting
Not Required
Reporting Time
7–10 Days
Gender
Male/Female
Age Group
All Age Groups
✔ Home collection available ✔ No hidden charges
Need help? Call 1800-123-4567
Kidney / Renal | Heart & Cardiac Health | Liver Test | Comprehensive Diabetes | Comprehensive Thyroid | Child & Adolescent Health | Women's Health | Men's Health | Cancer | Immunity & Allergy Test | Fever & Infection | Pancreas | Vitamins & Nutrition | Sexual Wellness/STDs | Bone & Joint Health | Hormonal | Urine & Stool Test | Infectious Diseases | Covid & Respiratory Health | Obesity & Metabolism | Dental & Oral Health | Eye & Vision Screening | Skin & Hair Health | Senior Citizen Checkups | Mental Health & Wellness | Autoimmune Disorder | Pregnancy & Fertility